Finanzdaten der Rxo Inc-Aktie (RXO)
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 5.47%1,871.00 | 1,774.00 | 1,425.00 | 1,469.00 | 1,421.00 |
5.69%223.00 | 211.00 | 197.00 | - | - | |
| Selling, General, and Administrative | 5.69%223.00 | 211.00 | 197.00 | - | - |
| Operating Income/Loss | 1,600%17.00 | 1.00 | -28.00 | -42.00 | -7.00 |
| Income/Loss From Continuing Operations Before Tax | 175.00%6.00 | -8.00 | -49.00 | -51.00 | -15.00 |
| Income Tax Expense/Benefit, Deferred | 3.00 | - | -15.00 | -6.00 | -2.00 |
| Income Tax Expense/Benefit | 200.00%3.00 | 1.00 | -13.00 | -5.00 | -1.00 |
133.33%3.00 | -9.00 | -36.00 | -46.00 | -14.00 | |
| Attributable To Parent | 133.33%3.00 | -9.00 | -36.00 | -46.00 | -14.00 |
| Available To Common Stockholders, Basic | 133.33%3.00 | -9.00 | -36.00 | -46.00 | -14.00 |
| Basic Average Shares | 0.02%169.67 | 169.65 | 169.10 | 0.09 | 168.58 |
| Diluted Average Shares | 1.39%172.01 | 169.65 | 169.10 | 0.09 | 168.58 |
| Basic Earnings Per Share | 140.00%0.02 | -0.05 | -0.21 | -0.27 | -0.08 |
| Diluted Earnings Per Share | 140.00%0.02 | -0.05 | -0.21 | -0.27 | -0.08 |